|
US11384350B2
(en)
|
2014-12-15 |
2022-07-12 |
The Regents Of The University Of California |
Cytotoxic molecules responsive to intracellular ligands for selective T cell mediated killing
|
|
CA3008162A1
(en)
|
2014-12-15 |
2016-06-23 |
The Regents Of The University Of California |
Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20
|
|
US10765699B2
(en)
|
2015-02-06 |
2020-09-08 |
National University Of Singapore |
Methods for enhancing efficacy of therapeutic immune cells
|
|
TW202444897A
(zh)
*
|
2015-06-25 |
2024-11-16 |
美商生物細胞基因治療有限公司 |
嵌合抗原受體(car)、組合物及其使用方法
|
|
US20220348633A1
(en)
*
|
2015-06-25 |
2022-11-03 |
Icell Gene Therapeutics Llc |
COMPOUND CHIMERIC ANTIGEN RECEPTOR (cCAR) TARGETING MULTIPLE ANTIGENS, COMPOSITIONS AND METHOD OF USE THEREOF
|
|
US20220241327A1
(en)
*
|
2015-06-25 |
2022-08-04 |
Icell Gene Therapeutics Llc |
Chimeric Antigen Receptor (CAR) Targeting Multiple Antigens, Compositions and Methods of Use Thereof
|
|
DK3368571T5
(da)
|
2015-10-30 |
2024-09-30 |
Univ California |
Transformerende, vækstfaktor-beta-responsive polypeptider og fremgangsmåder til anvendelse deraf
|
|
WO2017075537A1
(en)
|
2015-10-30 |
2017-05-04 |
Aleta Biotherapeutics Inc. |
Compositions and methods for treatment of cancer
|
|
CN108472365A
(zh)
|
2015-10-30 |
2018-08-31 |
艾丽塔生物治疗剂公司 |
用于肿瘤转导的组合物和方法
|
|
US11384156B2
(en)
*
|
2016-07-25 |
2022-07-12 |
The Nemours Foundation |
Adoptive T-cell therapy using EMPD-specific chimeric antigen receptors for treating IgE-mediated allergic diseases
|
|
AU2017306557B2
(en)
|
2016-08-03 |
2023-08-03 |
Washington University |
Gene editing of CAR-T cells for the treatment of T cell malignancies with chimeric antigen receptors
|
|
JP2019530440A
(ja)
|
2016-09-02 |
2019-10-24 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
インターロイキン６受容体α結合単鎖可変断片を含む方法および組成物
|
|
AU2017357649A1
(en)
*
|
2016-11-11 |
2019-05-23 |
Autolus Limited |
Chimeric antigen receptor
|
|
CN110121505B
(zh)
|
2016-12-28 |
2023-08-01 |
株式会社绿十字细胞治疗 |
嵌合抗原受体和表达其的自然杀伤细胞
|
|
EP3568466A4
(en)
|
2017-01-10 |
2020-07-15 |
The General Hospital Corporation |
TARGETED T CELLS WITH CYTOTOXICITY TO IMMUNOSUPPRESSIVE CELLS
|
|
CA3048648A1
(en)
*
|
2017-01-10 |
2018-07-19 |
The General Hospital Corporation |
T cells expressing a chimeric antigen receptor
|
|
IL268895B2
(en)
|
2017-02-28 |
2025-05-01 |
Vor Biopharma Inc |
Compositions and methods for inhibition of lineage specific proteins
|
|
JP2020516654A
(ja)
|
2017-04-13 |
2020-06-11 |
センティ バイオサイエンシズ インコーポレイテッド |
組み合わせがん免疫療法
|
|
CA3059444A1
(en)
*
|
2017-04-14 |
2018-10-18 |
The General Hospital Corporation |
Chimeric antigen receptor t cells targeting the tumor microenvironment
|
|
US11344578B2
(en)
*
|
2017-04-19 |
2022-05-31 |
Board Of Regents, The University Of Texas System |
Immune cells expressing engineered antigen receptors
|
|
BR112019023608A2
(pt)
|
2017-05-12 |
2020-05-26 |
Crispr Therapeutics Ag |
Materiais e métodos para células manipuladas e seus usos em imuno-oncologia
|
|
US11166985B2
(en)
|
2017-05-12 |
2021-11-09 |
Crispr Therapeutics Ag |
Materials and methods for engineering cells and uses thereof in immuno-oncology
|
|
JP2020524512A
(ja)
|
2017-06-21 |
2020-08-20 |
アイセル・ジーン・セラピューティクス・エルエルシー |
キメラ抗体受容体（ＣＡＲｓ）の組成物およびその使用方法
|
|
CN111094330A
(zh)
|
2017-07-03 |
2020-05-01 |
转矩医疗股份有限公司 |
编码免疫刺激融合分子的多核苷酸及其用途
|
|
WO2019028051A1
(en)
*
|
2017-07-31 |
2019-02-07 |
Lentigen Technology, Inc. |
COMPOSITIONS AND METHODS FOR TREATING CANCER BY ANTI-CD19 / CD20 IMMUNOTHERAPY
|
|
CN111247241A
(zh)
|
2017-08-10 |
2020-06-05 |
新加坡国立大学 |
T细胞受体缺陷型嵌合抗原受体t细胞和其使用方法
|
|
WO2019074983A1
(en)
|
2017-10-10 |
2019-04-18 |
Alpine Immune Sciences, Inc. |
CTLA-4 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
|
|
US11905528B2
(en)
*
|
2017-10-12 |
2024-02-20 |
Icell Gene Therapeutics Inc. |
Compound chimeric antigen receptor (cCAR) targeting multiple antigens, compositions and methods of use thereof
|
|
WO2019084240A1
(en)
|
2017-10-25 |
2019-05-02 |
Actinium Pharmaceuticals, Inc. |
METHODS OF TREATING CANCER USING RADIO-labeled CD45 ANTI-CD45 IMMUNOGLOBULIN AND ADOPTIVE CELLULAR THERAPIES
|
|
MX2020004572A
(es)
|
2017-11-01 |
2020-10-07 |
Juno Therapeutics Inc |
Receptores de antigenos quimericos especificos para el antigeno de maduracion de celulas b y polinucleotidos que codifican los mismos.
|
|
CA3080904A1
(en)
|
2017-11-01 |
2019-05-09 |
Juno Therapeutics, Inc. |
Antibodies and chimeric antigen receptors specific for b-cell maturation antigen
|
|
US11649294B2
(en)
|
2017-11-14 |
2023-05-16 |
GC Cell Corporation |
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
|
|
EP3712178A4
(en)
|
2017-11-14 |
2021-08-11 |
Green Cross Lab Cell Corporation |
ANTI-HER2 ANTIBODIES OR ANTIGIBODY FRAGMENT THEREOF AND CHIMERAIR ANTIGEN RECEPTOR WITH IT
|
|
EP3512874A2
(en)
*
|
2017-11-30 |
2019-07-24 |
Grifols Diagnostic Solutions Inc. |
Immunoassays and engineered proteins for monitoring antibody treatments to the immune checkpoint inhibitors pd1 and pd-l1
|
|
WO2019140127A2
(en)
*
|
2018-01-10 |
2019-07-18 |
The General Hospital Corporation |
Immune cells expressing a chimeric antigen receptor
|
|
CN108314738B
(zh)
*
|
2018-01-29 |
2020-09-08 |
山东兴瑞生物科技有限公司 |
一种共表达细胞因子il-21的双特异性嵌合抗原受体、质粒、cik细胞及mm病应用
|
|
CN111801348A
(zh)
|
2018-02-09 |
2020-10-20 |
新加坡国立大学 |
活化性嵌合受体及其在自然杀伤细胞免疫疗法中的用途
|
|
WO2019160956A1
(en)
*
|
2018-02-13 |
2019-08-22 |
Novartis Ag |
Chimeric antigen receptor therapy in combination with il-15r and il15
|
|
SG11202007697VA
(en)
*
|
2018-02-15 |
2020-09-29 |
Memorial Sloan Kettering Cancer Center |
Foxp3 targeting agent compositions and methods of use for adoptive cell therapy
|
|
WO2019165121A1
(en)
|
2018-02-21 |
2019-08-29 |
Board Of Regents, The University Of Texas System |
Methods for activation and expansion of natural killer cells and uses therof
|
|
EP3765093A4
(en)
*
|
2018-03-15 |
2021-12-08 |
Fundamental Solutions Corporation |
PROGRAMMABLE IMMUNOCYTE RECEPTOR COMPLEX SYSTEM
|
|
US11168138B2
(en)
|
2018-03-26 |
2021-11-09 |
Altor Bioscience, Llc |
Anti-PDL1, IL-15 and TGF-beta receptor combination molecules
|
|
SG11202008976YA
(en)
|
2018-04-02 |
2020-10-29 |
Nat Univ Singapore |
Neutralization of human cytokines with membrane-bound anti-cytokine non-signaling binders expressed in immune cells
|
|
CN111954527A
(zh)
*
|
2018-04-09 |
2020-11-17 |
梅约医学教育与研究基金会 |
治疗移植物抗宿主病的方法和材料
|
|
CA3291067A1
(en)
*
|
2018-04-12 |
2025-11-29 |
Kite Pharma, Inc. |
Chimeric receptor t cell treatment using characteristics of the tumor microenvironment
|
|
EP3561053A1
(en)
*
|
2018-04-26 |
2019-10-30 |
Baylor College of Medicine |
Immune effector cells and molecular adaptors with an antigen cytokine complex for effective cancer immunotherapy
|
|
US20210094994A1
(en)
*
|
2018-04-27 |
2021-04-01 |
Baylor College Of Medicine |
Car t cells with one or more interleukins
|
|
US12473342B2
(en)
|
2018-04-27 |
2025-11-18 |
The Trustees Of The University Of Pennsylvania |
Chimeric antigen receptor T regulatory cells for the treatment of atherosclerosis
|
|
CN110468105B
(zh)
*
|
2018-05-09 |
2024-03-22 |
恺兴生命科技(上海)有限公司 |
表达il-18r结合蛋白的免疫效应细胞
|
|
EP3790629A1
(en)
|
2018-05-11 |
2021-03-17 |
CRISPR Therapeutics AG |
Methods and compositions for treating cancer
|
|
CN112566643A
(zh)
*
|
2018-06-12 |
2021-03-26 |
加利福尼亚大学董事会 |
用于治疗癌症的单链双特异性嵌合抗原受体
|
|
DK3806903T5
(da)
|
2018-06-14 |
2024-08-19 |
2Seventy Bio Inc |
Cd79a kimæriske antigenreceptorer
|
|
WO2019246593A2
(en)
*
|
2018-06-22 |
2019-12-26 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to target cll-1 and cd123 for the treatment of acute myeloid leukemia and related disorders
|
|
US11951131B2
(en)
|
2018-07-03 |
2024-04-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-SLAMF7 chimeric antigen receptors
|
|
CN108864307A
(zh)
*
|
2018-07-23 |
2018-11-23 |
北京多赢时代科技有限公司 |
信号肽优化靶向cd19的嵌合抗原受体、表达该嵌合抗原受体的t细胞及制备方法和应用
|
|
US20210079111A1
(en)
*
|
2018-08-04 |
2021-03-18 |
AbCyte Therapeutics Inc. |
Cd19-cd20 bispecific and dual passway car-t and methods for use thereof
|
|
CN110862967A
(zh)
*
|
2018-08-27 |
2020-03-06 |
天津天锐生物科技有限公司 |
一种不依赖细胞因子培养的自然杀伤细胞系silk-nk
|
|
WO2020047164A1
(en)
|
2018-08-28 |
2020-03-05 |
Vor Biopharma, Inc |
Genetically engineered hematopoietic stem cells and uses thereof
|
|
EP3845654A4
(en)
*
|
2018-08-31 |
2022-05-11 |
Noile-Immune Biotech, Inc. |
Car-expressing t cells and car expression vector
|
|
EP3847197A1
(en)
*
|
2018-09-05 |
2021-07-14 |
Poseida Therapeutics, Inc. |
Allogeneic cell compositions and methods of use
|
|
CN110950965B
(zh)
*
|
2018-09-26 |
2021-10-15 |
重庆精准生物技术有限公司 |
抗人cd123的嵌合抗原受体及其应用
|
|
JP2022501067A
(ja)
*
|
2018-09-26 |
2022-01-06 |
上海恒潤達生生物科技有限公司Hrain Biotechnology Co., Ltd. |
Ｂｃｍａ及びｃｄ１９を標的とするキメラ抗原受容体、並びにその使用
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
US20210338729A1
(en)
*
|
2018-10-12 |
2021-11-04 |
Icell Gene Therapeutics Llc |
CHIMERIC ANTIGEN RECEPTORS (CARs) COMPOSITIONS AND METHODS OF USE THEREOF
|
|
TW202035685A
(zh)
*
|
2018-10-17 |
2020-10-01 |
美商聖堤生物科技股份有限公司 |
組合癌症免疫療法
|
|
US11419898B2
(en)
|
2018-10-17 |
2022-08-23 |
Senti Biosciences, Inc. |
Combinatorial cancer immunotherapy
|
|
WO2020092839A1
(en)
|
2018-10-31 |
2020-05-07 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
CA3116412A1
(en)
|
2018-10-31 |
2020-05-07 |
Humanigen, Inc. |
Materials and methods for treating cancer
|
|
EP3873540A4
(en)
|
2018-10-31 |
2022-07-27 |
Mayo Foundation for Medical Education and Research |
METHODS AND MATERIALS FOR THE TREATMENT OF CANCER
|
|
MX2021005022A
(es)
*
|
2018-11-01 |
2021-09-08 |
Juno Therapeutics Inc |
Receptores de antigenos quimericos especificos para el miembro d del grupo 5 de la clase c del receptor acoplado a proteina g (gprc5d).
|
|
SG11202104188VA
(en)
|
2018-11-01 |
2021-05-28 |
Juno Therapeutics Inc |
Methods for treatment using chimeric antigen receptors specific for b-cell maturation antigen
|
|
WO2020088631A1
(en)
|
2018-11-01 |
2020-05-07 |
Gracell Biotechnologies (Shanghai) Co., Ltd. |
Compositions and methods for t cell engineering
|
|
CA3120563A1
(en)
|
2018-11-26 |
2020-06-04 |
Nkarta, Inc. |
Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
|
|
WO2020113054A1
(en)
|
2018-11-30 |
2020-06-04 |
Mustang Bio, Inc. |
Methods of treatment using decitabine and a cd123-targeted therapy
|
|
US11793834B2
(en)
|
2018-12-12 |
2023-10-24 |
Kite Pharma, Inc. |
Chimeric antigen and T cell receptors and methods of use
|
|
US12600760B2
(en)
|
2018-12-13 |
2026-04-14 |
The General Hospital Corporation |
Chimeric antigen receptors targeting CD79B and CD19
|
|
SG11202106952UA
(en)
|
2018-12-24 |
2021-08-30 |
Haidong Huang |
Recombinant human 2ig-b7-h3 protein coding gene, recombinant vector, host cell comprising the same, pharmaceutical composition and use thereof
|
|
EP3908613A4
(en)
*
|
2019-01-07 |
2022-10-19 |
Celluris Participações Ltda. |
BISPECIFIC IN-TANDEM RECEPTOR CAR AND METHODS FOR MODULATION OF THE TUMOR MICROAREA
|
|
CA3128518A1
(en)
*
|
2019-02-01 |
2020-08-06 |
Actinium Pharmaceuticals, Inc. |
Molecules and their derivatives directed against cd45
|
|
WO2020180882A1
(en)
|
2019-03-05 |
2020-09-10 |
Nkarta, Inc. |
Cd19-directed chimeric antigen receptors and uses thereof in immunotherapy
|
|
KR102298639B1
(ko)
|
2019-03-28 |
2021-09-07 |
한국생명공학연구원 |
면역세포의 제조방법 및 그의 용도
|
|
CA3136618A1
(en)
*
|
2019-04-10 |
2020-10-15 |
Elevatebio Technologies, Inc. |
Flt3-specific chimeric antigen receptors and methods of using the same
|
|
CN110055281B
(zh)
*
|
2019-04-25 |
2020-09-01 |
山东大学第二医院 |
一种用于制备car-t的慢病毒载体及其构建方法和应用
|
|
AU2020267057A1
(en)
|
2019-04-30 |
2021-11-18 |
Crispr Therapeutics Ag |
Allogeneic cell therapy of B cell malignancies using genetically engineered T cells targeting CD19
|
|
WO2020223445A1
(en)
|
2019-04-30 |
2020-11-05 |
Senti Biosciences, Inc. |
Chimeric receptors and methods of use thereof
|
|
AU2020265741A1
(en)
*
|
2019-05-01 |
2021-11-25 |
Editas Medicine, Inc. |
Cells expressing a recombinant receptor from a modified TGFBR2 Locus, related polynucleotides and methods
|
|
EP3747904A1
(en)
*
|
2019-06-03 |
2020-12-09 |
Universität Regensburg |
Cd25-specific chimeric antigen receptors and their uses
|
|
JP2022535138A
(ja)
*
|
2019-06-07 |
2022-08-04 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
Ｃｄ２８および４－１ｂｂに個々に連結したデュアルｃａｒを発現するｔ細胞
|
|
JP7649258B2
(ja)
*
|
2019-06-14 |
2025-03-19 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
癌を治療するための組成物および方法
|
|
US20230181027A1
(en)
*
|
2019-06-28 |
2023-06-15 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating neuromyelitis optica spectrum diseases
|
|
CN112204135B
(zh)
*
|
2019-07-06 |
2026-03-06 |
苏州克睿基因生物科技有限公司 |
一种表达cd3抗体受体复合物的免疫细胞及其用途
|
|
EP3997129B1
(en)
|
2019-07-11 |
2025-11-26 |
Valkyr, Inc. |
System and methods relating to chimeric autoantibody receptors
|
|
AU2020315213A1
(en)
*
|
2019-07-17 |
2022-02-03 |
National University Of Singapore |
Functional binders synthesized and secreted by immune cells
|
|
CN110452294B
(zh)
|
2019-08-06 |
2020-08-07 |
复旦大学 |
五种铰链区及其嵌合抗原受体和免疫细胞
|
|
WO2021041936A1
(en)
*
|
2019-08-28 |
2021-03-04 |
Montefiore Medical Center |
Cd25 chimeric antigen receptors and uses thereof
|
|
WO2021057906A1
(zh)
*
|
2019-09-25 |
2021-04-01 |
科济生物医药（上海）有限公司 |
表达il-15的免疫效应细胞
|
|
WO2021064718A1
(en)
*
|
2019-10-01 |
2021-04-08 |
Case Western Reserve University |
Targeting b cell activating factor receptor (baff-r) using ligand-based chimeric antigen receptor (car)-t cells
|
|
CA3153441A1
(en)
*
|
2019-10-01 |
2021-04-08 |
Reshmi Parameswaran |
Targeting b cell activating factor receptor (baff-r) using ligand-based chimeric antigen receptor (car)-t cells
|
|
AU2020361683A1
(en)
*
|
2019-10-11 |
2022-05-19 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for targeting CD13 and TIM-3 with CAR T cells to treat acute myeloid leukemia
|
|
TWI717880B
(zh)
|
2019-10-24 |
2021-02-01 |
中國醫藥大學附設醫院 |
Hla-g特異性嵌合抗原受體、核酸、hla-g特異性嵌合抗原受體表達質體、表達hla-g特異性嵌合抗原受體細胞、其用途以及用於治療癌症之醫藥組合物
|
|
CN115925976A
(zh)
*
|
2019-11-21 |
2023-04-07 |
博生吉医药科技(苏州)有限公司 |
Cd7-car-t细胞及其制备和应用
|
|
CN115551887A
(zh)
*
|
2019-12-05 |
2022-12-30 |
维萨列克斯股份有限公司 |
通用细胞疗法的免疫逃逸机制的调节剂
|
|
CN115335399A
(zh)
|
2019-12-06 |
2022-11-11 |
朱诺治疗学股份有限公司 |
针对gprc5d靶结合结构域的抗独特型抗体以及相关组合物和方法
|
|
MX2022010685A
(es)
*
|
2020-02-27 |
2022-09-23 |
Novartis Ag |
Metodos de produccion de celulas que expresan receptores de antigeno quimericos.
|
|
WO2021207171A1
(en)
*
|
2020-04-06 |
2021-10-14 |
St. Jude Children's Research Hospital, Inc. |
B7-h3 chimeric antigen receptors
|
|
CN111411085A
(zh)
*
|
2020-04-10 |
2020-07-14 |
格源致善(上海)生物科技有限公司 |
一种嵌合抗原受体t细胞及其应用
|
|
CN113527507A
(zh)
*
|
2020-04-16 |
2021-10-22 |
上海赛比曼生物科技有限公司 |
靶向cd22的嵌合抗原受体及其制法和应用
|
|
CN115777017A
(zh)
*
|
2020-05-06 |
2023-03-10 |
亘喜生物科技（上海）有限公司 |
用于t细胞工程改造的组合物及方法
|
|
WO2021226551A1
(en)
|
2020-05-08 |
2021-11-11 |
Alpine Immune Sciences, Inc. |
April and baff inhibitory immunomodulatory proteins and methods of use thereof
|
|
US20230338531A1
(en)
*
|
2020-08-20 |
2023-10-26 |
City Of Hope |
Compositions and uses of cd45 targeted chimeric antigen receptor modified t cells
|
|
AU2021334950A1
(en)
*
|
2020-08-24 |
2023-03-02 |
Charité - Universitätsmedizin Berlin |
Chimeric antigen receptor (CAR)-expressing cells recognizing CEA
|
|
CN116568812A
(zh)
*
|
2020-09-08 |
2023-08-08 |
亘喜生物科技（上海）有限公司 |
用于t细胞工程化的组合物和方法
|
|
WO2022061837A1
(en)
*
|
2020-09-27 |
2022-03-31 |
Jiangsu Cell Tech Medical Research Institute Co., Ltd. |
Fibronectin extra domain b (edb) -specific car-t for cancer
|
|
CN116783283A
(zh)
*
|
2020-11-13 |
2023-09-19 |
Gpb科学有限公司 |
产生具有增加的核酸摄取的细胞群体的方法
|
|
US11459372B2
(en)
|
2020-11-30 |
2022-10-04 |
Crispr Therapeutics Ag |
Gene-edited natural killer cells
|
|
US11661459B2
(en)
|
2020-12-03 |
2023-05-30 |
Century Therapeutics, Inc. |
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
|
|
US20220195396A1
(en)
*
|
2020-12-03 |
2022-06-23 |
Century Therapeutics, Inc. |
Genetically Engineered Cells and Uses Thereof
|
|
TW202237827A
(zh)
|
2020-12-03 |
2022-10-01 |
美商世紀治療股份有限公司 |
經基因工程改造之細胞及其用途
|
|
US11473060B2
(en)
|
2020-12-30 |
2022-10-18 |
Crispr Therapeutics Ag |
Compositions and methods for differentiating stem cells into NK cells
|
|
CN115786271B
(zh)
*
|
2021-01-12 |
2025-07-22 |
上海雅科生物科技有限公司 |
靶向cd7的工程化免疫细胞、嵌合抗原受体、cd7阻断分子及应用
|
|
CN112778427B
(zh)
*
|
2021-01-29 |
2022-03-15 |
武汉思安医疗技术有限公司 |
双特异性cs1-bcma car-t细胞及其应用
|
|
US20220267423A1
(en)
*
|
2021-02-22 |
2022-08-25 |
IgGenix, Inc. |
Ige antibodies cross-reactive to allergens and tumor antigens
|
|
CN112698037B
(zh)
*
|
2021-03-25 |
2021-06-25 |
北京积水潭医院 |
一种检测多发性骨髓瘤治疗效果的抗体组合物及其试剂盒和应用
|
|
WO2022234976A1
(ko)
*
|
2021-05-04 |
2022-11-10 |
주식회사 이뮤노로지컬디자이닝랩 |
키메릭 항원 수용체(car)를 포함하는 형질전환된 항원 특이적 전문적 항원표출세포 및 이의 용도
|
|
KR102671411B1
(ko)
*
|
2021-05-11 |
2024-06-04 |
진화섭 |
Baff 세포외 도메인을 포함하는 키메릭 항원 수용체 및 이의 용도
|
|
CN115340610A
(zh)
*
|
2021-05-12 |
2022-11-15 |
珠海市丽珠单抗生物技术有限公司 |
双特异性car t细胞及其应用
|
|
CN113501884B
(zh)
*
|
2021-06-30 |
2022-03-22 |
徐州医科大学 |
靶向B7H3的全人源嵌合抗原受体、iNKT细胞及其用途
|
|
CN113549158B
(zh)
*
|
2021-07-19 |
2022-10-21 |
广州百暨基因科技有限公司 |
包含突变型il15以及嵌合抗原受体的融合蛋白
|
|
WO2023009989A1
(en)
*
|
2021-07-26 |
2023-02-02 |
Kite Pharma, Inc. |
Split chimeric antigen receptors and methods of use
|
|
WO2023028539A1
(en)
*
|
2021-08-24 |
2023-03-02 |
City Of Hope |
Nk cells expressing il-15 and checkpoint inhibitors for the treatment of cancer
|
|
KR20230032557A
(ko)
|
2021-08-31 |
2023-03-07 |
주식회사 이뮤노로지컬디자이닝랩 |
Baff 세포외 도메인을 포함하는 재조합 단백질 및 이를 유효성분으로 포함하는 암의 치료용 약학적 조성물
|
|
EP4401776A4
(en)
*
|
2021-09-16 |
2025-08-13 |
Gt Biopharma Inc |
FUSION PROTEINS TARGETING B7-H3 AND METHODS OF USE THEREOF
|
|
EP4433512A4
(en)
*
|
2021-11-19 |
2025-12-31 |
Univ Pennsylvania |
Genetically modified pan-leukocyte-specific CD45 antigen to facilitate T-lymphocyte therapy
|
|
US20230210900A1
(en)
*
|
2022-01-04 |
2023-07-06 |
Kyverna Therapeutics, Inc. |
Methods for treating autoimmune diseases
|
|
CN116606378A
(zh)
*
|
2022-02-08 |
2023-08-18 |
中国医学科学院血液病医院(中国医学科学院血液学研究所) |
靶向cd52的嵌合抗原受体及其应用
|
|
EP4272754A1
(en)
|
2022-05-04 |
2023-11-08 |
Universitätsklinikum Hamburg-Eppendorf |
Method for producing cells expressing a chimeric antigen receptor (car)
|
|
EP4522751A1
(en)
*
|
2022-05-10 |
2025-03-19 |
Miltenyi Biotec B.V. & Co. KG |
Compositions comprising il-15, il-15 receptor alpha and the intracellular signaling domain of cd2 for immune cell therapy
|
|
WO2024026455A2
(en)
*
|
2022-07-29 |
2024-02-01 |
Shoreline Biosciences, Inc. |
Methods and compositions for generating chimeric antigen receptor-monocytes/macrophages
|
|
EP4487868A1
(en)
|
2023-07-06 |
2025-01-08 |
Universitätsklinikum Hamburg-Eppendorf |
Modified nk cell expressing a chimeric antigen receptor
|
|
WO2025059162A1
(en)
|
2023-09-11 |
2025-03-20 |
Dana-Farber Cancer Institute, Inc. |
Car-engager containing il-2 variants to enhance the functionality of car t cells
|
|
WO2025072372A1
(en)
*
|
2023-09-26 |
2025-04-03 |
The General Hospital Corporation |
Car-t cells expressing vegf binding proteins
|
|
CN117050195B
(zh)
*
|
2023-10-13 |
2023-12-19 |
旭和（天津）医药科技有限公司 |
一种靶向baffr嵌合抗原受体、car-t细胞和应用
|
|
WO2025264723A1
(en)
*
|
2024-06-18 |
2025-12-26 |
The University Of Chicago |
Co-expressed chimeric antigen receptors for cancer treatment
|
|
WO2026082736A1
(en)
*
|
2024-10-14 |
2026-04-23 |
Cimeio Therapeutics Ag |
Chimeric antigen receptor (car) that targets receptor-type tyrosine phosphatase c (cd45) and its use to related applications
|